<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>Administration of anti-<z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumor</z:e> <z:mp ids='MP_0001651'>necrosis</z:mp> factor (anti-TNF) agents is beneficial in a variety of <z:hpo ids='HP_0011010'>chronic</z:hpo> inflammatory conditions, including <z:hpo ids='HP_0003765'>psoriasis</z:hpo> </plain></SENT>
<SENT sid="1" pm="."><plain>We describe 5 patients in whom psoriasiform <z:mp ids='MP_0001212'>skin lesions</z:mp> developed 6-9 months after the initiation of anti-TNF therapy for longstanding, seropositive <z:hpo ids='HP_0001370'>rheumatoid arthritis</z:hpo> (etanercept or adalimumab), typical <z:e sem="disease" ids="C0038013" disease_type="Disease or Syndrome" abbrv="">ankylosing spondylitis</z:e> (infliximab), and Adamantiades-<z:chebi fb="6" ids="22696">Beh</z:chebi>Ã§et's disease (infliximab) </plain></SENT>
<SENT sid="2" pm="."><plain>In <z:hpo ids='HP_0000001'>all</z:hpo> 5 patients, the underlying disease had responded well to anti-TNF therapy </plain></SENT>
<SENT sid="3" pm="."><plain>Four patients developed a striking pustular eruption on the palms and/or soles accompanied by plaque-type <z:hpo ids='HP_0003765'>psoriasis</z:hpo> at other skin sites, while 1 patient developed thick erythematous scaly plaques localized to the scalp </plain></SENT>
<SENT sid="4" pm="."><plain>In 3 patients there was nail involvement with <z:hpo ids='HP_0001806'>onycholysis</z:hpo>, yellow discoloration, and subungual <z:e sem="disease" ids="C0022593" disease_type="Disease or Syndrome" abbrv="">keratosis</z:e> </plain></SENT>
<SENT sid="5" pm="."><plain>Histologic findings from skin biopsies were consistent with <z:hpo ids='HP_0003765'>psoriasis</z:hpo> </plain></SENT>
<SENT sid="6" pm="."><plain>None of these patients had a personal or family history of <z:hpo ids='HP_0003765'>psoriasis</z:hpo> </plain></SENT>
<SENT sid="7" pm="."><plain>In <z:hpo ids='HP_0000001'>all</z:hpo> patients, <z:mp ids='MP_0001212'>skin lesions</z:mp> subsided either with topical treatment alone, or after discontinuation of the responsible anti-TNF agent </plain></SENT>
<SENT sid="8" pm="."><plain>The interpretation of this paradoxical side effect of anti-TNF therapy remains unclear but may relate to altered immunity induced by the inhibition of TNF activity in predisposed individuals </plain></SENT>
</text></document>